Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.36
Bid: 17.52
Ask: 18.48
Change: -0.23 (-1.31%)
Spread: 0.96 (5.479%)
Open: 17.98
High: 18.00
Low: 17.36
Prev. Close: 17.59
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

30 Jun 2017 08:00

RNS Number : 4826J
Nanoco Group PLC
30 June 2017
 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Total Voting Rights

 

In accordance with 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

 

As at 30 June 2017, the Company's issued share capital consisted of 238,291,328 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"). The Company holds 12,222 Ordinary Shares in Treasury, therefore, the total number of Ordinary Shares with voting rights is 238,279,106.

 

The above figure of 238,279,106 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA Disclosure and Transparency Rules.

 

- ENDS -

 

For further information, please contact:

Nanoco Tel: +44 (0) 161 603 7900

Dr Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com 

Peel Hunt Tel: +44 (0) 20 7418 8900

Adrian Trimmings

George Sellar

 

MHP Communications Tel: +44 (0) 20 3128 8570

Reg Hoare / Andrew Leach / Giles Robinson / Peter Lambie

nanoco@mhpc.com 

 

Notes to Editors

 

ABOUT NANOCO

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare and solar.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREVLFLDQFEBBE
Date   Source Headline
18th Dec 200612:15 pmRNSTotal Voting Rights
14th Dec 20067:01 amRNSResearch Update
12th Dec 20061:32 pmRNSHolding(s) in Company
8th Dec 200611:40 amRNSHolding(s) in Company
4th Dec 20067:01 amRNSResearch Update
1st Dec 20063:06 pmRNSHolding(s) in Company
22nd Nov 200610:00 amRNSHolding(s) in Company
20th Nov 20063:12 pmRNSHolding(s) in Company
16th Nov 20067:00 amRNSResearch Update
14th Nov 20064:09 pmRNSHolding(s) in Company
8th Nov 20069:08 amRNSDirector/PDMR Shareholding
6th Nov 200612:49 pmRNSHolding(s) in Company
2nd Nov 20062:01 pmRNSHolding(s) in Company
31st Oct 20069:47 amRNSHolding(s) in Company
31st Oct 20069:38 amRNSHolding(s) in Company
26th Oct 20067:01 amRNSDirector/PDMR Shareholding
25th Oct 20067:01 amRNSIssue of Equity
12th Oct 20067:00 amRNSRe Agreement
21st Sep 20069:46 amRNSDirector/PDMR Shareholding
18th Sep 200610:24 amRNSHolding(s) in Company
13th Sep 20068:54 amRNSHolding(s) in Company
12th Sep 200612:11 pmRNSHolding(s) in Company
12th Sep 20067:02 amRNSInterim Results
4th Sep 20067:01 amRNSNotice of Results
30th Aug 20062:39 pmRNSHolding(s) in Company
15th Aug 20067:01 amRNSNotice of Interim Results
9th Aug 20062:20 pmRNSHolding(s) in Company
20th Jun 20067:01 amRNSPh II Cataract Trial Starts
13th Jun 20067:00 amRNSPh IIb Hay Fever Trial Starts
24th May 20067:01 amRNSCase Western Collaboration
23rd May 20067:02 amRNSBoard Appointment
16th May 20067:02 amRNSUS Appointment
15th May 20067:04 amRNSConference Webcast
10th May 20064:26 pmRNSHolding(s) in Company
26th Apr 20064:50 pmRNSResult of AGM
4th Apr 20067:01 amRNSMerial Option Agreement
13th Mar 20067:02 amRNSBoston Conference Webcast
1st Mar 20069:27 amRNSDirector/PDMR Shareholding
28th Feb 20067:02 amRNSPreliminary Results
27th Feb 200610:06 amRNSPositive Preclinical Data
10th Feb 200611:49 amRNSHolding(s) in Company
12th Dec 20051:32 pmRNSHolding(s) in Company
15th Nov 20055:28 pmRNSHolding(s) in Company
15th Nov 200511:34 amRNSHolding(s) in Company
15th Nov 200511:31 amRNSHolding(s) in Company
15th Nov 200511:23 amRNSHolding(s) in Company
14th Nov 20057:01 amRNSChange of Adviser
9th Nov 200512:40 pmRNSResult of EGM
28th Oct 20053:09 pmRNSDirector/PDMR Shareholding
25th Oct 20057:02 amRNSBusiness Development Appt.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.